Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Cocaine Hydrochloride

    Client Email Product

    Cocaine Hydrochloride

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    GLOBAL SALES INFORMATION

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    5
    US DMFs Filed

    US DMFs Filed

    3
    CEP/COS Certifications

    CEP/COS Certifications

    1
    JDMFs Filed

    JDMFs Filed

    1
    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    2
    API REF. PRICE (USD / KG)

    0

    API Market Place

    0

    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    2
    Europe

    Europe

    0

    Canada

    Canada

    2
    Australia

    Australia

    0

    South Africa

    South Africa

    3
    Uploaded Dossiers

    Uploaded Dossiers

    1
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS

    0

    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    33

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    8
    REF STANDARD

    EDQM

    1

    USP

    1

    JP

    0

    Other Listed Suppliers

    3
    SERVICES

    0

    left grey arrow
    right gray arrow
    • SOLUTION;NASAL - 4%
    • SOLUTION;NASAL - 4%
    Full View ScreenFull Screen View
    Embera NeuroTherapeutics Announces First Subject Dosed in Phase 2
    Embera NeuroTherapeutics Announces First Subject Dosed in Phase 2

    https://www.businesswire.com/news/home/20200831005044/en/Embera-NeuroTherapeutics-Announces-Subject-Dosed-Phase-2

    BUSINESSWIRE
    31 Aug 2020
    Share Share
    Premier Biotech’s Oral Fluid Drug Testing Device Granted FDA Clearance
    Premier Biotech’s Oral Fluid Drug Testing Device Granted FDA Clearance

    https://www.businesswire.com/news/home/20180307006221/en

    BUSINESSWIRE
    07 Mar 2018
    Share Share
    Camino Pharma Co-Founder Receives $10.8 Million Grant for Dvp of Potential Drug
    Camino Pharma Co-Founder Receives $10.8 Million Grant for Dvp of Potential Drug

    http://www.prnewswire.com/news-releases/camino-pharma-co-founder-receives-108-million-grant-for-development-of-potential-drug-for-cocaine-and-nicotine-addiction-300526404.html

    PR NEWSWIRE
    27 Sep 2017
    Share Share
    Province to inspect Windsor police drug vault
    Province to inspect Windsor police drug vault

    http://windsorstar.com/news/local-news/province-to-inspect-windsor-police-drug-vault

    Sarah Sacheli WINDSORSTAR
    04 Jul 2017
    Share Share
    NAFDAC destroys N9.6 billion fake drugs
    NAFDAC destroys N9.6 billion fake drugs

    http://guardian.ng/news/nafdac-destroys-n9-6-billion-fake-drugs/

    Ann Godwin GUARDIAN
    24 Jan 2017
    Share Share
    Enlisting Beijing to help stop fentanyl exports won’t be easy
    Enlisting Beijing to help stop fentanyl exports won’t be easy

    http://www.theglobeandmail.com/opinion/enlisting-beijing-to-help-stop-fentanyl-exports-wont-be-easy/article33207872/

    CHARLES BURTON THE GLOBE AND MAIL
    06 Dec 2016
    Share Share
    DEA Proposes to Remove Cocaine Derivative [123I]Ioflupane from Schedule II of the CSA – Almost Five Years after Receipt of HHS’s Recommendation
    DEA Proposes to Remove Cocaine Derivative [123I]Ioflupane from Schedule II of the CSA – Almost Five Years after Receipt of HHS’s Recommendation

    http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/06/dea-proposes-to-remove-cocaine-derivative-123iioflupane-from-schedule-ii-of-the-csa-almost-five-year.html

    Karla L. Palmer FDA LAW BLOG
    04 Jun 2015
    Share Share
    Cody Laboratories, Inc., Ongoing Class II recall of C-Topical 4% CII (cocaine hydrochloride), topical solution, 4 ml bottle, (NDC 0527-1728-74), Rx Only, Manufactured for Lannett Company, Inc. Philadelphia, PA 19136 by Cody Laboratories, Inc. Cody, WY 82414 because of Labeling: Label mix-up; bottles were incorrectly labeled as 10 mL instead of correctly labeled as 4 mL
    Cody Laboratories, Inc., Ongoing Class II recall of C-Topical 4% CII (cocaine hydrochloride), topical solution, 4 ml bottle, (NDC 0527-1728-74), Rx Only, Manufactured for Lannett Company, Inc. Philadelphia, PA 19136 by Cody Laboratories, Inc. Cody, WY 82414 because of Labeling: Label mix-up; bottles were incorrectly labeled as 10 mL instead of correctly labeled as 4 mL

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0992-2015&w=05132015&lang=eng

    FDA
    13 May 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Veranova Cocaine Hydrochloride

    Access Virtual Booth

    Contact Supplier

    View Presentation

    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search